Incyte Corp (INCY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
60.68 -0.58 (-0.95%) 03/27/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 60.68 unch (unch) 16:36 ET
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select Fields| Symbol | INCY | MRNA | EXEL | ||
| Company | Incyte Corp | Moderna Inc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 61.55 | 31.54 | 37.25 | ||
| High | 61.63 | 32.57 | 38.16 | ||
| Low | 60.24 | 31.25 | 36.82 | ||
| Last | 60.68 | 32.12 | 36.84 | ||
| Change | -0.58 | +0.64 | -0.17 | ||
| % Change | -0.95% | +2.03% | -0.46% | ||
| Volume | 1,371,000 | 6,198,300 | 2,903,100 | ||
| 20-Day Average Volume | 2,169,945 | 9,416,525 | 2,896,050 | ||
| Previous Close | 61.26 | 31.48 | 37.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 65.91 | 33.45 | 37.58 | ||
| 20-Day Raw Stochastic | 14.63% | 31.58% | 19.49% | ||
| 20-Day Relative Strength | 33.41% | 44.49% | 51.98% | ||
| Weighted Alpha | -2.06 | -70.13 | +55.57 | ||
| Today's Opinion | 56% Sell | 100% Sell | 88% Buy | ||
| Previous Opinion | 56% Sell | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.17% since 03/20/25 | -1.02% since 03/20/25 | -0.91% since 03/20/25 | ||
| Low | 60.24 on 03/27/25 | 31.25 on 03/27/25 | 36.68 on 03/21/25 | ||
| High | 63.31 on 03/24/25 | 34.87 on 03/24/25 | 38.41 on 03/26/25 | ||
| 1-Month | |||||
| %Chg | -17.08% since 02/27/25 | +3.31% since 02/27/25 | -2.15% since 02/27/25 | ||
| Low | 58.46 on 03/18/25 | 29.35 on 03/04/25 | 36.07 on 03/18/25 | ||
| High | 73.63 on 02/28/25 | 38.12 on 03/13/25 | 40.02 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | -12.35% since 12/27/24 | -19.96% since 12/27/24 | +8.96% since 12/27/24 | ||
| Low | 58.46 on 03/18/25 | 29.25 on 02/14/25 | 31.90 on 01/24/25 | ||
| High | 76.96 on 02/07/25 | 48.92 on 01/07/25 | 40.02 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | -7.82% since 09/27/24 | -51.15% since 09/27/24 | +41.91% since 09/27/24 | ||
| Low | 58.46 on 03/18/25 | 29.25 on 02/14/25 | 25.17 on 10/10/24 | ||
| High | 83.95 on 11/08/24 | 67.96 on 09/30/24 | 40.02 on 03/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,855,280 | 12,170,891 | 10,358,396 | ||
| Shares Outstanding, K | 193,524 | 386,623 | 279,881 | ||
| Annual Sales | 4,241,220,000 | 3,236,000,000 | 2,168,700,000 | ||
| Annual Net Income | 32,610,000 | -3,561,000,000 | 521,270,000 | ||
| Last Quarter Sales | 1,178,700,000 | 966,000,000 | 566,750,000 | ||
| Last Quarter Net Income | 201,210,000 | -1,120,000,000 | 139,860,000 | ||
| 60-Month Beta | 0.76 | 1.86 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.43 on 02/10/25 | -2.50 on 02/14/25 | 0.55 on 02/11/25 | ||
| Latest Earnings Date | 04/29/25 | 05/01/25 | 04/29/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 365.18 | 0.00 | 21.55 | ||